1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Descriptive statistics of orbital lesion ADC across the largest source datasets (ADC in units of 10−3 mm2/s)
All Lesions (n = 183) Sepahdari et al13 (n = 50) Politi et al17 (n = 90) Razek et al16 (n = 43) Benign lesion ADC (mean, 95% CI) 1.42 ± 0.41 (1.34–1.51) 1.36 ± 0.41 (1.22–1.51) 1.39 ± 0.42 (1.25–1.54) 1.53 ± 0.35 (1.37–1.67) Malignant lesion ADC (mean, 95% CI) 0.90 ± 0.37 (0.83–0.98) 1.02 ± 0.42 (0.80–1.24) 0.88 ± 0.36 (0.79–0.98) 0.80 ± 0.34 (0.65–0.95) Lymphoma ADC (mean, 95% CI) 0.67 ± 0.09 (0.64–0.69) 0.69 ± 0.16 (0.58–0.86)a 0.67 ± 0.07 (0.60–0.75) 0.67 ± 0.07 (0.60–0.73)a Inflammatory lesion ADC (mean, 95% CI) 1.40 ± 0.31 (1.30–1.50) 1.42 ± 0.37 (1.24–1.60) 1.45 ± 0.26 (1.29–1.60) 1.24 ± 0.13 (1.18–1.33)a Area under ROC curve (95% CI) 0.84 (0.79–0.90) 0.74 (0.58–0.89) 0.86 (0.79–0.94) 0.95 (0.87–1.0)
↵a The 25th-75th percentile range was reported due to a sample size too small to assume normal distribution.